Identification of Peptide Leads to Inhibit Hepatitis C Virus: Inhibitory Effect of Plectasin Peptide Against Hepatitis C Serine Protease-Reference-Cited by-同舟云学术

Identification of Peptide Leads to Inhibit Hepatitis C Virus: Inhibitory Effect of Plectasin Peptide Against Hepatitis C Serine Protease

Published:2016-08-06 Issue:2 Volume:23 Page:163-170
ISSN:1573-3149
Container-title:International Journal of Peptide Research and Therapeutics
language:en
Short-container-title:Int J Pept Res Ther

Author:

Abdulrahman Ammar Y.,Rothan Hussin A.,Rashid Nurshamimi Nor,Lim See Khai,Sakhor Wajihah,Tee Kah Ching,Teoh Teow Chong,Rahman Noorsaadah A.,Yusof Rohana

Funder

Ministry of Higher education/Malaysia

Publisher

Springer Science and Business Media LLC

Subject

Drug Discovery,Molecular Medicine,Biochemistry,Bioengineering,Analytical Chemistry

Link

http://link.springer.com/content/pdf/10.1007/s10989-016-9544-6.pdf

Reference35 articles.

1. Alexopoulou A, Papatheodoridis GV (2012) Current progress in the treatment of chronic hepatitis C. World J Gastroenterol 18(42):6060–6069. doi: 10.3748/wjg.v18.i42.6060

2. Ashfaq UA, Javed T, Rehman S, Nawaz Z, Riazuddin S (2011) An overview of HCV molecular biology, 21 replication, and immune responses. Virol J 8. doi: 10.1186/1743-422x-8-161

3. Asselah T (2014) Daclatasvir plus sofosbuvir for HCV infection: an oral combination therapy with high antiviral efficacy. J Hepatol 61(2):435–438. doi: 10.1016/j.jhep.2014.04.042

4. Bhatia HK, Singh H, Grewal N, Natt NK (2014) Sofosbuvir: a novel treatment option for chronic hepatitis C infection. J Pharmacol Pharmacother 5(4):278–284. doi: 10.4103/0976-500X.142464

5. Brinch KS, Frimodt-Moller N, Hoiby N, Kristensen HH (2009) Influence of antidrug antibodies on plectasin efficacy and pharmacokinetics. Antimicrob Agents Chemother 53(11):4794–4800. doi: 10.1128/AAC.00440-09

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review and perspective on bioinformatics tools using machine learning and deep learning for predicting antiviral peptides;Molecular Diversity;2023-08-26

2. Antimicrobial peptides: natural or synthetic defense peptides against HBV and HCV infections;VirusDisease;2022-11-10

3. Cell-Based High-Throughput Screening Protocol for Discovering Antiviral Inhibitors Against SARS-COV-2 Main Protease (3CLpro);Molecular Biotechnology;2021-01-19

4. Rational drug discovery: Ellagic acid as a potent dual‐target inhibitor against hepatitis C virus genotype 3 (HCV G3) NS3 enzymes;Chemical Biology & Drug Design;2020-07-26

5. Novel Quinazoline derivatives inhibited HCV Serine protease and viral replication in Huh-7 cells;2019-06-14